Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole.
Conclusions: In Asian patients with GERD, treatment with dexlansoprazole modified-release indicates a favorable efficacy and safety profile in relieving heartburn and acid regurgitation symptoms.
PMID: 31597230 [PubMed - as supplied by publisher]
Source: Journal of Neurogastroenterology and Motility - Category: Gastroenterology Tags: J Neurogastroenterol Motil Source Type: research
More News: Acid Reflux | Brain | Dexilant | Endoscopy | Erosive Esophagitis | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Heartburn | Hong Kong Health | Neurology | South Korea Health | Study | Taiwan Health